Related Experiment Videos
Intra-abdominal infections: considerations for the use of the carbapenems
Ioannis P Kioumis1, Joseph L Kuti, David P Nicolau
1Center for Anti-infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
Abstract:
Intra-abdominal infection remains a common and frequently severe medical condition, carrying with it significant morbidity and mortality. These infections are almost always polymicrobial in nature as they are caused by mixed aerobic/anaerobic intestinal flora. Despite substantial improvements in both the medical and surgical management of these infections over the last several decades, there remains an opportunity to further enhance the utilization of adjunctive antibiotic therapy. As a result of the epidemiology and the current resistance profile of the infecting pathogens, the carbapenems represent a class of antibiotics that are considered appropriate for the treatment of severe intra-abdominal infections. This review will discuss the classification and microbiology of these infections and emerging resistance in the pathogens of interest. The review also and focuses on the role of the carbapenems in the management of the constellation of diseases known as intra-abdominal infection.
Insights
Severe intra-abdominal infections, often caused by mixed bacteria, require effective antibiotic therapy. Carbapenems are crucial for treating these complex infections, considering pathogen resistance patterns.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Intra-abdominal infections (IAIs) are common, severe conditions with high morbidity and mortality.
- IAIs are typically polymicrobial, involving both aerobic and anaerobic intestinal flora.
- Despite advances, adjunctive antibiotic therapy in IAIs can be further optimized.
Purpose of the Study:
- To review the classification and microbiology of intra-abdominal infections.
- To discuss emerging resistance patterns in pathogens causing IAIs.
- To focus on the role of carbapenems in managing IAIs.
Main Methods:
- Literature review on intra-abdominal infections.
- Analysis of carbapenem antibiotics' efficacy and role.
- Examination of pathogen microbiology and resistance trends.
Main Results:
- Intra-abdominal infections are polymicrobial and pose significant clinical challenges.
- Carbapenem antibiotics are vital for treating severe IAIs due to pathogen profiles.
- Emerging resistance necessitates careful consideration of antibiotic selection.
Conclusions:
- Carbapenems are essential in the management of severe intra-abdominal infections.
- Understanding microbiology and resistance is key to effective treatment.
- Optimizing adjunctive antibiotic strategies, including carbapenems, is ongoing.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Clinical Significance of Antibiotic Resistance
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection I: Introduction